The Impact of Rockall Risk Scoring System on Management of Upper Gastrointestinal System Bleeding
The Impact of Rockall Risk Scoring System on Timing of Endoscopy, Length of Hospital Stay, Morbidity and Mortality in Patients With Upper Gastrointestinal System Bleeding
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Osman Kones, MD
- Phone Number: 090-542-36968282
- Email: osman.kones@beah.gov.tr
Study Locations
-
-
-
Istanbul, Turkey, 34147
- Recruiting
- Dr. Sadi Konuk Training and Research Hospital
-
Contact:
- Halil Alis, MD
- Phone Number: 090-505-2327425
- Email: halilalis@yahoo.com
-
Principal Investigator:
- Osman Kones, MD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Clinical diagnosis of upper gastrointestinal system bleeding
- Rockall score of 1 or less
- Volunteers
- Agreement with the terms of informed consent
Exclusion Criteria:
- Uncertain clinical diagnosis of upper gastrointestinal system bleeding
- Rockall score of 2 or greater
- Deterioration in hemodynamic parameters during follow-up
- Unwilling patients to join the study
- Disagreement with the terms of informed consent
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Go-home group
The patients with a Rockall score of 0 or 1 will be prescribed medical therapy, and will be scheduled for elective gastroscopy.
|
Gastroscopy
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The necessity of emergency endoscopy.
Time Frame: 1 month
|
1 month
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Morbidity
Time Frame: 1 month
|
1 month
|
|
Length of hospital stay
Time Frame: 1 month
|
1 month
|
|
Mortality
Time Frame: 1 month
|
1 month
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Rockall-GIH
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.